Amelioration of SLE-like manifestations in (NZBxNZW)F1 mice following treatment with a peptide based on the complementarity determining region 1 of an autoantibody is associated with a down-regulation of apoptosis and of the pro-apoptotic factor JNK kinas
Keywords: Lupus; CDR-based peptides; Apoptosis; p21Ras pathway; JNK kinase; Immunomodulation; (NZBxNZW)F1 mice;